Quality and Patient Safety


The Quality and Patient Safety Committee is committed to providing and promoting the dialogue around patient safety and quality improvement in order to best serve our patients and CAS members. The committee continues to support and establish initiatives which address patient safety concerns such as safe medication practices, workplace human factors, QI-methodology, and equal access to resources and learnings for all communities. The committee also continues to engage with other CAS Committees, and advises the CAS Board of Directors regarding patient safety and quality improvement matters.

What's New?

CAS has released a medication safety bulletin, with regards to the succinylcholine chloride shortage in Canada. Please download and share with your colleagues.

Date: November 17th, 2023
File Format: PDF


CAS Medication Shortage Bulletin: Succinylcholine Chloride
 

CAS has released a medication safety bulletin, with regards to the Sandoz Ketamine Hydrochloride shortages in Canada. Please download and share with your colleagues.

Date: February 24th, 2023
File Format: PDF


CAS Medication Shortage Bulletin - Ketamine Hydrochloride

The committee has released its latest safety bulletin, available in the March issue of the Anesthesia News newsletter. 

March 2023 - Equity: The Forgotten QI Element

 

Quality and Patient Safety Chair(s)

Dr Maha Said Saud Al-Mandhari
Chair | Toronto, ON
Dr Conor Gerard Mc Donnell
Co-Chair | Toronto, ON

If you have a question for the committee, please contact us.

Committee Members

  • Dr Gregory Dobson
  • Dr Esther Shin Hyun Kang
  • Dr Niveditha Karuppiah
  • Dr Olajide Kowe
  • Dr Kelly Mayson
  • Dr Melissa Setiawan
  • Dr Kevin Bach, Resident Representative
  • Ms Cristina Mita